Azacitidine is a type of chemotherapy called a hypomethylating agent that interferes with the growth and spread of cancer cells in the body.
| SparkCures ID | 57 |
|---|---|
| Developed By | Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb |
| Brand Name | Vidaza® |
| Generic Name | Azacitidine |
| Additional Names | 5-Azacytidine, Ladakamycin |
| Treatment Classifications |
There are no resources, links or videos to display for this treatment.